DRUG NEWS: Older drug performs as well as newcomers

December 2005 
Volume 35  Number 12
Pages 30 - 30
  PDF Version Available!


In a large study sponsored by the National Institute of Mental Health, the first-generation antipsychotic perphenazine (Trilafon) performed as well as newer, more expensive drugs in treating schizophrenia. A total of 1,493 patients with schizophrenia were assigned to receive one of five drugs: perphenazine, olanzapine (Zyprexa), quetiapine (Seroquel), risperidone (Risperdal), or ziprasidone (Geodon) for an 18-month study period. The researchers found that perphenazine was as effective at treating schizophrenia as the other four drugs.

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member